Cynthia LaConte is the CEO of Dohmen, a services company focused on reducing the cost and complexity of development, approval and commercialization of products for life science innovators. Dohmen propels start-up, mid-tier and Fortune 500 BioPharma, MedTech and Advanced Therapy companies with support services spanning the entire continuum; from pre-approval regulatory consulting to in-home patient services.
While serving as VP of Procurement for Dohmen’s pharmaceutical wholesaling division, Cynthia created a joint venture called DDN/Obergfel. DDN brought a new, outsourced distribution model to vertically integrated pharmaceutical companies looking for a way to preserve capital. In 1996, she acquired Obergfel and founded DDN, serving as President until 2006, when she was named COO of Dohmen.
As COO, she advanced the sale of Dohmen’s $2 billion wholesale division. She took the helm as CEO in 2009, with a vision of creating a more efficient, affordable and accessible healthcare supply system and built an entirely new company dedicated to supporting the industry-shifting paradigm of personalized medicine. Using her extensive experience in strategic planning, entrepreneurship and change management, Cynthia brought new life to the fifth-generation family-owned company.
Since 2009, Dohmen has acquired five life science service companies, increased revenue by more than 30%, and become a trusted partner to more than 600 drug and device companies, connecting innovators with the patients they serve. With more than 650,000 square feet of facility space and 800 employees in WI, TN, CA, MO, CO and Israel, Dohmen processes more than $9 billion in transactions annually and touches more than 16 million consumers.
Cynthia also founded the Dohmen Company Foundation in 2008. Each year a percentage of Dohmen’s profits fund the foundation, and in six years, Dohmen has given more than $10 million, connecting 213 million people around the world to lifesaving healthcare products and services.
She is on the Board of Directors for The Dohmen Company, The Dohmen Company Foundation, BioForward and The Medical College of Wisconsin.
Whether she’s at the helm of Dohmen Life Science Services or focused on new programs for the Dohmen Foundation, she is devoted to one vision: to create a more efficient, effective, and easy-to-use healthcare system.